Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
16.31
-0.60 (-3.55%)
Dec 17, 2025, 1:50 PM EST - Market open
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $967.95 million as of December 17, 2025. Its market cap has decreased by -18.74% in one year.
Market Cap
967.95M
Enterprise Value
520.55M
1-Year Change
-18.74%
Ranking
Category
Stock Price
$16.31
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has decreased from $974.02M to $967.95M, a decrease of -0.62%. That is a compound annual growth rate of -0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 1.00B | -8.71% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |